North America Prebiotics for Infant Formula Market - Industry Trends and Forecast To 2027
- DAT3435558
- 90 Pages
- December 2019
- Food and Beverages
Market Segmentation:
By Type (Human Milk Oligosaccharides (HMOS), Galactooligosaccharides (GOS), Fructooligosaccharides (FOS), Mannan-Oligosaccharides (MOS), Polydextrose (PDX), Lactulose (LOS), Inulin), Source (Bacteria, Algae, Fungi, Plants & Vegetables), Grade (Inorganic, Organic), Form (Powder, Liquid), Product Type (Standard Formula, Toddler Formula, Follow Up Formula, Special Formula), Infant Age (0-6 Months, 6-12 Months, 1-3 Years), Country (U.S., Canada, Mexico)
Some of the major factors contributing to the growth of the North America market:
Rising Number from Preterm/Premature Babies
Increased Research Initiative for New Product Development
Market Players:
The key market players for North America prebiotics for infant formula market are listed below:
• Jennewein Biotechnologie GmbH
• zuChem Inc
• Biosynth Carbosynth
• Elicityl SA
• Dextra Laboratories Limited
• Glycom A/S
• Tereos
• Ingredion Incorporated
• Royal FrieslandCampina N.V
• Südzucker AG
• Cargill, Incorporated
• Fonterra Co-operative Group
• Royal Cosun
• COSUCRA
• New Francisco (Yunfu City) Biotechnology Corporation Limited
• Dana Dairy Group
• Glycosyn LLC
• DuPont
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 MULTIVARIATE MODELING
2.8 PRODUCT TIMELINE CURVE
2.9 SECONDARY SOURCES
2.10 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 EVOLUTION
5.1 EVOLUTION OF INFANT FORMULA
5.2 EVOLUTION OF PREBIOTICS FORMULA
6 REGULATIONS & QUALITY REQUIREMENTS
6.1 REGULATIONS
6.1.1 FDA
6.1.1.1 GRAS NOTICE NO. GRN 000849
6.1.1.2 GRAS NOTICE NO. GRN 00859
6.1.1.3 GRAS NOTICE NO. GRN 000797
6.1.1.4 GRAS NOTICE NO. GRN 000766
6.1.1.5 GRAS NOTICE NO. GRN 000749
6.1.1.6 GRAS NOTICE NO. GRN 000735
6.1.1.7 GRAS NOTICE NO. GRN 000729
6.1.1.8 GRAS NOTICE NO. GRN 000717
6.1.1.9 GRAS NOTICE NO. GRN 000721
6.1.1.10 GRAS NOTICE NO. GRN 000659
6.1.1.11 GRAS NOTICE NO. GRN 000650
6.1.1.12 GRAS NOTICE NO. GRN 000623
6.1.1.13 GRAS NOTICE NO. GRN 000620
6.1.2 EUROPEAN UNION
6.1.2.1 COMMISSION DIRECTIVE 2006/141/EC
6.1.3 AUSTRALIA NEW ZEALAND FOOD STANDARDS CODE
6.1.3.1 STANDARD 2.9.1
6.1.3.2 STANDARD 2.9.2
6.1.3.3 STANDARD 2.9.3
6.2 QUALITY REQUIREMENTS
7 CLINICAL TRIALS
7.1 NCT03994315
7.2 NCT03884309
7.3 NCT02594683
7.4 NCT03661736
7.5 NCT03666572
7.6 NCT03866837
7.7 NCT03476889
8 INFANT FORMULA BRAND ANALYSTS
8.1 ABBOTT
8.2 MEAD JOHNSON & COMPANY, LLC
8.3 DANONE NUTRICIA
8.4 NESTLE
8.5 PERRIGO NUTRITIONALS
8.6 HOCHDORF HOLDING AG
9 MARKET OVERVIEW
9.1 DRIVERS
9.1.1 RISING NUMBER FROM PRETERM/PREMATURE BABIES
9.1.2 INCREASED RESEARCH INITIATIVE FOR NEW PRODUCT DEVELOPMENT
9.1.3 HEALTH BENEFITS ASSOCIATED WITH PREBIOTICS
9.1.4 GROWING CONCERN AND DEMAND FOR THE HEALTHY BABY FOOD
9.1.5 RISING POPULATION OF INFANT
9.2 RESTRAINTS
9.2.1 STRINGENT REGULATION AND APPROVAL CRITERIA SET BY GOVERNMENTS
9.2.2 RISING AWARENESS TOWARDS MOTHER FEEDING FOR INFANT
9.3 OPPORTUNITIES
9.3.1 RAPID DEVELOPMENT IN CHICORY ROOT BASED PREBIOTICS
9.3.2 EMERGING DEMAND IN DEVELOPING NATIONS
9.3.3 STRENGTHENING TRADE RELATIONSHIP BETWEEN DIFFERENT NATIONS
9.4 CHALLENGE
9.4.1 RISING NUMBER OF PRODUCT RECALLS FOR INFANT FORMULA DUE TO CONTAMINATION
10 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE
10.1 OVERVIEW
10.2 HUMAN MILK OLIGOSACCHARIDES (HMOS)
10.2.1 FUCOSYLLACTOSE
10.2.1.1 NEUTRAL FUCOSYLATE OLIGOSACCHARIDES
10.2.1.2 NON-FUCOSYLATED OLIGOSACCHARIDES
10.2.2 LACTO-N- TETRAOSE (LNT) & LACTO-N-NEOTETRAOSE (LNNT)
10.2.3 SIALYLLACTOSE
10.3 FRUCTOOLIGOSACCHARIDES (FOS)
10.3.1 LONG CHAIN FOS (LCFOS)
10.3.2 SINGLE CHAIN FOS (SCFOS)
10.4 GALACTOOLIGOSACCHARIDES (GOS)
10.4.1 LACTOSE DERIVED
10.4.2 GALACTOSE DERIVED
10.5 INULIN
10.6 POLYDEXTROSE (PDX)
10.7 MANNAN-OLIGOSACCHARIDES (MOS)
10.8 LACTULOSE (LOS)
11 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE
11.1 OVERVIEW
11.2 PLANTS & VEGETABLES
11.2.1 WHEAT
11.2.2 CHICORY ROOT
11.2.3 BANANAS
11.2.4 LEEKS
11.2.5 TOMATOES
11.2.6 OTHERS
11.3 BACTERIA
11.4 FUNGI
11.5 ALGAE
11.6 OTHERS
12 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE
12.1 OVERVIEW
12.2 INORGANIC
12.3 ORGANIC
13 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM
13.1 OVERVIEW
13.2 POWDER
13.3 LIQUID
14 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE
14.1 OVERVIEW
14.2 STANDARD FORMULA
14.3 SPECIAL FORMULA
14.4 FOLLOW UP FORMULA
14.5 TODDLER FORMULA
15 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE
15.1 OVERVIEW
15.2 6-12 MONTHS
15.3 0-6 MONTHS
15.4 1-3 YEARS
16 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GEOGRAPHY
16.1 NORTH AMERICA
16.1.1 U.S.
16.1.2 CANADA
16.1.3 MEXICO
17 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
18 COMPANY PROFILE
18.1 ROYAL FRIESLANDCAMPINA N.V.
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 CARGILL, INCORPORATED.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENT
18.3 INGREDION INCORPORATED
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 BENEO (A SUBSIDIARY OF SÜDZUCKER)
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENTS
18.5 FONTERRA CO-OPERATIVE GROUP
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 BIOSYNTH CARBOSYNTH
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENTS
18.7 COSUCRA
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENTS
18.8 DANA DAIRY GROUP
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 DEXTRA LABORATORIES LIMITED
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.10 DUPONT.
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 PRODUCT PORTFOLIO
18.10.4 RECENT DEVELOPMENTS
18.11 ELICITYL SA
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENT
18.12 GLYCOM A/S
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 GLYCOSYN LLC.
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENTS
18.14 JENNEWEIN BIOTECHNOLOGIE GMBH
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENTS
18.15 NEW FRANCISCO (YUNFU CITY) BIOTECHNOLOGY CORPORATION LIMITED
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENTS
18.16 ROYAL COSUN
18.16.1 COMPANY SNAPSHOT
18.16.2 REVENUE ANALYSIS
18.16.3 APPLICATION PORTFOLIO
18.16.4 RECENT DEVELOPMENT
18.17 TEREOS
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 PRODUCT PORTFOLIO
18.17.4 RECENT DEVELOPMENT
18.18 ZUCHEM INC.
18.18.1 COMPANY SNAPSHOT
18.18.2 PRODUCT PORTFOLIO
18.18.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
UU
TABLE 1 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 2 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 3 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 4 NORTH AMERICA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 5 NORTH AMERICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 6 NORTH AMERICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 7 NORTH AMERICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 8 NORTH AMERICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 9 NORTH AMERICA INULIN IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 10 NORTH AMERICA POLYDEXTROSE (PDX) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 11 NORTH AMERICA MANNAN-OLIGOSACCHARIDES (MOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 12 NORTH AMERICA LACTULOSE (LOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 13 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)
TABLE 14 NORTH AMERICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 15 NORTH AMERICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)
TABLE 16 NORTH AMERICA BACTERIA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 17 NORTH AMERICA FUNGI IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 18 NORTH AMERICA ALGAE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 19 NORTH AMERICA OTHERS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 20 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)
TABLE 21 NORTH AMERICA INORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 22 NORTH AMERICA ORGANIC IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 23 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)
TABLE 24 NORTH AMERICA POWDER IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 25 NORTH AMERICA LIQUID IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 26 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 27 NORTH AMERICA STANDARD FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 28 NORTH AMERICA SPECIAL FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 29 NORTH AMERICA FOLLOW UP FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 30 NORTH AMERICA TODDLER FORMULA IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 31 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)
TABLE 32 NORTH AMERICA 6-12 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 33 NORTH AMERICA 0-6 MONTHS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 34 NORTH AMERICA 1-3 YEARS IN PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 35 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 36 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 37 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 38 NORTH AMERICA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 39 NORTH AMERICA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 40 NORTH AMERICA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 41 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)
TABLE 42 NORTH AMERICA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)
TABLE 43 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)
TABLE 44 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)
TABLE 45 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 46 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)
TABLE 47 U.S. PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 48 U.S. HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 49 U.S. FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 50 U.S. GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 51 U.S. FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 52 U.S. PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)
TABLE 53 U.S. PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)
TABLE 54 U.S. PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)
TABLE 55 U.S. PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)
TABLE 56 U.S. PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 57 U.S. PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)
TABLE 58 CANADA PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 59 CANADA HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 60 CANADA FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 61 CANADA GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 62 CANADA FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 63 CANADA PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)
TABLE 64 CANADA PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)
TABLE 65 CANADA PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)
TABLE 66 CANADA PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)
TABLE 67 CANADA PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 68 CANADA PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)
TABLE 69 MEXICO PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 70 MEXICO HUMAN MILK OLIGOSACCHARIDES (HMOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 71 MEXICO FUCOSYLLACTOSE IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 72 MEXICO GALACTOOLIGOSACCHARIDES (GOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 73 MEXICO FRUCTOOLIGOSACCHARIDES (FOS) IN PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 74 MEXICO PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)
TABLE 75 MEXICO PLANTS & VEGETABLES IN PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE, 2018-2027 (USD MILLION)
TABLE 76 MEXICO PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE, 2018-2027 (USD MILLION)
TABLE 77 MEXICO PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM, 2018-2027 (USD MILLION)
TABLE 78 MEXICO PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)
TABLE 79 MEXICO PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE, 2018-2027 (USD MILLION)
Similar Reports
Driven by improving living standards of people and a fast-growing macro-economy, China has remained the largest beer-consuming country worldwide for the 12th consecutive year since 2003, and the largest beer-producing nation globally in the past years. This report focuses on systematic evaluation and analysis of Internal Risks (arising within the industry development itself) and External Risks (ar...
- Publish Date: November 26, 2014
- $800
Summary Based on products type, the report describes major products type share of regional market. Products mentioned as follows: By Type Microparticulated Protein Modified Whey Protein Concentrate Others Based on region, the report describes major regions market by vendor, products and application. Regions mentioned as follows: North America Europe Asia RoW Based on application, the repor...
- Publish Date: March 1, 2017
- $840
Summary The global Oat Protein market is estimated to reach 1.4 K MT in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc. Based on products type, the report describes major products type share of regio...
- Publish Date: April 15, 2017
- $840
